MarketPeel
Insider Trading Intelligence
AT

Adam Taich

TXG
CHIEF FINANCIAL OFFICER · 10X GENOMICS, INC. · CIK 0001971187
FILING MIX · LIFETIME38%/62%
BUYS
3
SELLS
5
TOTAL VALUE
$1.10M
COMPANIES
1
ACTIVE SINCE
Oct 2024
HOLDINGS NOW
379,898
AVG SELL PX
$17.70
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Adam Taich, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+4.90%+0.87%+4.03%+3.06%
14d4+50.00%+0.44%+0.91%-0.46%+1.15%
30d4+50.00%+2.84%+1.19%+1.66%+1.15%
60d4+25.00%+13.58%+4.89%+8.69%+10.19%
90d4+25.00%+22.69%+4.20%+17.60%+13.99%
180d4(1 pending)+0.00%+45.56%+9.78%+49.75%+49.75%
1y4(3 pending)+0.00%+180.80%+27.31%+153.49%+153.49%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TXG · 379,898 shares · as of May 22, 2026
098,749197,498296,247394,99620252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 3 buys / 5 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TXG
10X GENOMICS, INC.
SALE
Chief Financial Officer
15,098$24.44$369.0K379,898May 22, 2026May 27, 2026View →
TXG
10X GENOMICS, INC.
PURCHASEGRANT
Stock grant
106,579394,996Feb 26, 2026Mar 2, 2026View →
TXG
10X GENOMICS, INC.
SALE
Chief Financial Officer
8,968$18.58$166.6K288,417Feb 23, 2026Feb 25, 2026View →
TXG
10X GENOMICS, INC.
SALE
Chief Financial Officer
11,888$19.00$225.9K297,385Nov 24, 2025Nov 25, 2025View →
TXG
10X GENOMICS, INC.
SALE
Chief Financial Officer
22,315$13.79$307.7K309,273Aug 22, 2025Aug 26, 2025View →
TXG
10X GENOMICS, INC.
SALE
Chief Financial Officer
4,044$8.30$33.6K331,588May 22, 2025May 27, 2025View →
TXG
10X GENOMICS, INC.
PURCHASEGRANT
Stock grant
133,928335,632Mar 17, 2025Mar 19, 2025View →
TXG
10X GENOMICS, INC.
PURCHASEGRANT
Stock grant
201,704201,704Oct 23, 2024Mar 19, 2025View →
Other insiders · TXG
Loading peer insiders…
About this filer
CIK 0001971187
ROLE
Chief Financial Officer
PRIMARY
TXG
COMPANIES
1
ACTIVE SINCE
Oct 2024
MARKETPEEL · /INSIDER/0001971187DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback